Evidence map›Paper›PMID 30552794›Full record

ReviewMolecular oncology2019

Cancer survivorship: an integral part of Europe's research agenda.

Pernilla Lagergren, Anna Schandl, Neil K Aaronson, Hans-Olov Adami, Francesco de Lorenzo, Louis Denis, Sara Faithfull, Lifang Liu, Franḉoise Meunier, Cornelia Ulrich and 1 more

Abstract readReview
In one paragraph

Review in Molecular oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Functional limitations among adult cancer survivors in the United States.Journal of cancer survivorship : research and practice · 2026
    Article
  15. Article
  16. Health-related quality of life in cancer survivors aged 65 and older: impact of diagnosis and treatment and perceived decline associated with aging.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pernilla LagergrenSurgical Care Science, Department of Molecular medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Anna SchandlSurgical Care Science, Department of Molecular medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Neil K AaronsonDivision of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Hans-Olov AdamiDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Francesco de LorenzoEuropean Cancer Patient Coalition, Brussels, Belgium.
Louis DenisOncology Centre Antwerp, Belgium.
Sara FaithfullFaculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Lifang LiuFédération of European Academies of Medicine, Brussels, Belgium.
Franḉoise MeunierFédération of European Academies of Medicine, Brussels, Belgium.
Cornelia UlrichHuntsman Cancer Institute, Salt Lake City, UT, USA.
European Academy of Cancer Sciences

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer survivorship has traditionally received little prioritisation and attention. For a long time, the treatment of cancer has been the main focus of healthcare providers' efforts. It is time to increase the amount of attention given to patients' long-term well-being and their ability to return to a productive and good life. This article describes the current state of knowledge and identifies research areas in need of development to enable interventions for improved survivorship for all cancer patients in Europe. The article is summed up with 11 points in need of further focus.

Indexed as

Biomedical ResearchSurvivorshipCancer Care FacilitiesEuropeHumansNeoplasmsQuality of Lifecancer researchcomprehensive cancer centreslong-term effectsresearch programmessurvivors

Identifiers

PMID30552794
PMCPMC6396379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.